Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medidata Solutions Prices Initial Public Offering
NEW YORK – June 25, 2009 – Medidata Solutions , a leading global provider of hosted clinical development solutions, today announced the pricing of its initial public offering of 6,300,000 shares of common stock at $14.00 per share. In addition, selling stockholders have granted the
View HTML
Toggle Summary Medidata Solutions Unveils Program to Recognize Clinical Trial Technology Partners
New Initiative Designed to Boost Collaborative Innovation among Leading Solution Providers to Advance Interoperability across Clinical Trial Systems
View HTML
Toggle Summary Medidata Solutions’ Customers Honored in CIO 100 Awards
Wyeth Research and Array BioPharma Recognized for Generating Business Value and Achieving Innovation through Implementation of Medidata Rave
View HTML
Toggle Summary Medidata Solutions Introduces Unique Site Visit Reporting Capability Within EDC/CDM Software
New Tool Further Improves Productivity of Clinical Study Monitors and Enhances Cross-Study Operational Visibility for Study Managers
View HTML
Toggle Summary U-Systems, Inc. Selects Medidata Rave® for SOMO•INSIGHT Study ofAutomated Breast Ultrasound System
Medidata Solutions Chosen for Flexible, Fast and Cost-Effective Implementation and eLearning Capabilities
View HTML
Toggle Summary Cystic Fibrosis Foundation Therapeutics Implements Medidata Rave at Coordinating Center for Clinical Research
Medidata Solutions Selected for Track Record of Creating Increased Efficiencies and Cost Savings in Academic Studies
View HTML
Toggle Summary Medidata Solutions Files Registration Statement for Initial Public Offering
NEW YORK, N.Y. – January 26, 2009 – Medidata Solutions, Inc., a leading global provider of hosted clinical development solutions, today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for an initial public offering of its common stock.
View HTML
Toggle Summary Stiefel Laboratories Implements Medidata Rave® to Achieve Immediate Cost Savings across Global Clinical Studies
Medidata Solutions Selected for Commitment to Customer Needs, Broad Functionality and Integration Capabilities
View HTML
Toggle Summary Medidata Solutions Executives to Lead Sessions at January DIA Events
Protocol Design, CDISC, Regulatory Challenges and Late-Phase Trials Top Agenda at DIA Japan Conference and Webinar
View HTML
Toggle Summary Quintiles Strengthens Relationship with Medidata Solutions through ASPire to Win Accreditation
World’s Largest CRO Completes Highest Level of Medidata Rave Enablement
View HTML

Investor Contact

Betsy Frank
+1 917 522 4620
bfrank@mdsol.com